Physician profile
Rickey Herrmann
NPI 1992802524
$1,378.55
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $264 · 2024: $19.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $315.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $193.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.38 | 2019-2020 | |
| Pfizer INC. | $125.66 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $78.10 | 2019-2020 | |
| Novo Nordisk INC | $75.96 | 2019 | |
| Amarin Pharma, INC. | $66.80 | 2019-2020 | |
| Lupin INC. | $50.83 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.19 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $39.67 | 2019 | |
| Lilly USA, LLC | $38.20 | 2019-2020 | |
| Amgen INC. | $37.58 | 2019-2020 | |
| Orexo US, INC. | $36.09 | 2019 | |
| Seqirus USA INC | $19.86 | 2024 | Flucelvax |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.04 | 2019 | |
| Genentech USA, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rickey Herrmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.